FDA Approves Vabrinty (leuprolide acetate) for Advanced Prostate Cancer
FDA approves new drug Vabrinty for advanced prostate cancer.
The FDA approved Vabrinty (leuprolide acetate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered subcutaneous…
The FDA approved Vabrinty (leuprolide acetate) to treat advanced prostate cancer. It is a hormone therapy that lowers testosterone levels. T…
FDA Approves Talvey (talquetamab) for Relapsed/Refractory Multiple Myeloma
FDA approves new multiple myeloma drug Talvey for certain patients.
The FDA has approved Talvey (talquetamab) for adult patients with relapsed or refractory multiple myeloma who have received at least four pr…
The FDA approved Talvey (talquetamab) for adults with multiple myeloma who have tried at least four other treatments. It is for patients who…
FDA Approves Tecvayli (teclistamab) for Relapsed or Refractory Multiple Myeloma
FDA approves new drug Tecvayli for advanced multiple myeloma.
The FDA approved Tecvayli (teclistamab) for relapsed or refractory multiple myeloma in combination with daratumumab and hyaluronidase-fihj a…
The FDA approved Tecvayli (teclistamab) for adults with multiple myeloma that has come back or not responded to treatment. It is used alone …
FDA Approves Zoladex (goserelin) for Multiple Indications Including Prostate Cancer and Endometriosis
FDA approves Zoladex for prostate cancer, endometriosis, and breast cancer.
The FDA approved Zoladex (goserelin) for use in combination with flutamide for locally confined prostate cancer, palliative treatment of adv…
The FDA has approved Zoladex (goserelin) to treat prostate cancer, endometriosis, and advanced breast cancer. It is given as a shot every 28…
FDA Approves VABRINTY (leuprolide acetate) for Advanced Prostate Cancer
FDA approves Vabrinty for advanced prostate cancer with flexible dosing.
The FDA approved VABRINTY (leuprolide acetate) for the treatment of advanced prostate cancer. It is a GnRH agonist administered subcutaneous…
The FDA approved Vabrinty (leuprolide acetate) for advanced prostate cancer. It is a hormone therapy given as a shot every 1 to 6 months. Th…
Narrative review on immune microenvironment evolution in serrated neoplasia and colorectal cancer
New immune signals found in early colon growths before cancer starts
This narrative review synthesizes evidence on immune microenvironment evolution in serrated neoplasia pathway-associated tumors and colorect…
Scientists found immune system changes in early colon growths that could help predict which patients might benefit from new immune therapies
Case report of penpulimab, nab-paclitaxel, and anlotinib in porocarcinoma
Immunotherapy-Chemo Mix Shows Promise Against Stubborn Skin Cancer
This case report and literature review describes a 78-year-old female with porocarcinoma treated with penpulimab plus nab-paclitaxel, then a…
• A rare skin cancer slowed with immunotherapy plus chemo • Helps patients with porocarcinoma lacking treatment options • Still experimental
Network Meta-Analysis Compares FLT3 Inhibitors in Acute Myeloid Leukemia
Three FLT3 inhibitors show promise for AML patients
This network meta-analysis of 6128 acute myeloid leukemia patients compared FLT3 inhibitors. Gilteritinib and midostaurin improved complete …
Gilteritinib and midostaurin boost remission rates; gilteritinib and quizartinib improve survival in AML.
Case report and literature review on oxaliplatin and tegafur for AEG with intramural metastasis
A rare cancer spread inside the esophagus wall needs careful treatment plans for older adults
This case report and literature review examines a 77-year-old male with adenocarcinoma of the esophagogastric junction and esophageal intram…
A doctor reviewed a rare case where cancer spread inside the esophagus wall. This condition often means the disease is already in the body. …
Systematic review and meta-analysis on alopecia areata and skin cancer risk
Alopecia areata patients may have lower risk of certain skin cancers based on new review data
This systematic review and meta-analysis synthesized eight studies on skin cancer risk in patients with alopecia areata. The analysis found …
This review found that people with hair loss might have a lower chance of getting melanoma. Other skin cancers showed a similar trend but th…
Literature review on primary CNS MALT lymphoma treatment and diagnosis
A Rare Brain Tumor in the Ventricles Was Found and Treated
This literature review and case report describes a 62-year-old man with primary central nervous system mucosa-associated lymphoid tissue lym…
A 62-year-old man had a rare brain tumor inside a fluid-filled ventricle, and a new treatment plan kept it from coming back.
Systematic review and meta-analysis of proton therapy for intracranial meningioma reports pooled outcomes
Proton therapy for brain tumors shows strong control with fewer side effects
This systematic review and meta-analysis of 1,431 adult meningioma patients treated with proton therapy found a pooled complication rate of …
Proton therapy offers effective tumor control with fewer side effects for patients with brain meningiomas, especially those near sensitive a…